Cryptotanshinone alleviates polycystic ovary syndrome in rats by regulating the HMGB1/TLR4/NF-κB signaling pathway

Cryptotanshinone (CRY) has been demonstrated to reverse reproductive disorders. However, whether CRY is effective in the treatment of polycystic ovary syndrome (PCOS) remains unknown. The aim of the present study was to evaluate the therapeutic potential of CRY in PCOS. A rat model of PCOS was estab...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med Rep
Principais autores: Yang, Yijiao, Yang, Ling, Qi, Cao, Hu, Guohua, Wang, Longhui, Sun, Zhuojun, Ni, Xiaorong
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533513/
https://ncbi.nlm.nih.gov/pubmed/32901834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11469
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados